Advertisement

  • Making Clinical Trials More Inclusive

    Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

    by Ashley P. Taylor

  • What Do Clinical Trial Endpoints Really Measure?

    A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

    by Jon Kelvey

  • Treating Breast Cancer in Men

    Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.

    by Marilyn Fenichel

  • Forward Look

    A Matter of Age

    Cell and molecular biologist Ashani Weeraratna discusses how older patients respond to immunotherapy.

    by Sue Rochman

  • Forward Look

    Treating Head and Neck Skin Cancers

    A study suggests high-risk patients do not need chemotherapy.

    by Stephen Ornes

  • Forward Look

    Breaking Down Breakthrough Cancer Therapies

    Drugs approved through this pathway may have limited evidence.

    by Lindsey Konkel

  • Tomorrow’s Trials

    New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience.

    by Bradley Jones

  • Forward Look

    What’s Next?

    Off-the-shelf equivalents to CAR-T cell therapy are emerging.

    by Bradley Jones

  • From the Editor-In-Chief

    Improving Health After Treatment

    The U.S. health care system must adapt to the needs of cancer survivors.

    by William G. Nelson, MD, PhD

  • Getting a Read on Cancer

    Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.

    by Kate Yandell

Advertisement
Advertisement

From the AACR

Advertisement

Video

Bob Riter: The Bridge Builder

Advertisement

social media

donate to the AACR